Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study (Q39632529)

From Wikidata
Jump to navigation Jump to search
scientific article published on 4 April 2012
edit
Language Label Description Also known as
English
Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study
scientific article published on 4 April 2012

    Statements

    Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study (English)
    Alessandro M Minisini
    Nicola Battelli
    Alberto Ravaioli
    Roberta Di Marsico
    Charles R Coombes
    Justin Stebbing

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit